Baker Bros. Advisors »

Bicara Therapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $21M 833k 25.47

More positions owned by Baker Bros. Advisors

BeiGene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Kymera Therapeutics (KYMR)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Replimune Group (REPL)
Alkermes SHS (ALKS)
Denali Therapeutics (DNLI)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)

View all positions for Baker Bros. Advisors

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics